BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 31341906)

  • 1. Neutrophil-to-Lymphocyte Ratio in Ovarian Cancer Patients with Low CA125 Concentration.
    Zhang H; Huo Q; Huang L; Cheng Y; Liu Y; Bao H
    Biomed Res Int; 2019; 2019():8107906. PubMed ID: 31341906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of serum D-dimer, CA125, and neutrophil-to-lymphocyte ratio in differentiating ovarian cancer and endometriosis.
    Chen L; Wang X; Shu J; Xu S; Wu Q; Yu Y
    Int J Gynaecol Obstet; 2019 Nov; 147(2):212-218. PubMed ID: 31469423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance and predictors of the neutrophil-to-lymphocyte ratio in ovarian cancer.
    Williams KA; Labidi-Galy SI; Terry KL; Vitonis AF; Welch WR; Goodman A; Cramer DW
    Gynecol Oncol; 2014 Mar; 132(3):542-50. PubMed ID: 24462730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible surrogate marker for an effective dose-dense chemotherapy in treating ovarian cancer.
    Huang CY; Yang YC; Wang KL; Chen TC; Chen JR; Weng CS; Chien HJ; Chang CL
    Taiwan J Obstet Gynecol; 2016 Jun; 55(3):405-9. PubMed ID: 27343324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of CA125, platelet count and neutrophil to lymphocyte ratio on the immune system of ovarian cancer patients.
    Baert T; Van Camp J; Vanbrabant L; Busschaert P; Laenen A; Han S; Van Nieuwenhuysen E; Vergote I; Coosemans A
    Gynecol Oncol; 2018 Jul; 150(1):31-37. PubMed ID: 29751991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined use of CA125, neutrophil/lymphocyte ratio and platelet/lymphocyte ratio for the diagnosis of borderline and malignant epithelial ovarian tumors.
    Huang K; Xu S; Wang J; Ge L; Xu J; Jia X
    J Ovarian Res; 2023 Feb; 16(1):37. PubMed ID: 36759870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of neutrophil/lymphocyte and platelet/lymphocyte ratios in the early diagnosis of malignant ovarian masses.
    Yildirim MA; Seckin KD; Togrul C; Baser E; Karsli MF; Gungor T; Gulerman HC
    Asian Pac J Cancer Prev; 2014; 15(16):6881-5. PubMed ID: 25169540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Value of the Neutrophil/Lymphocyte Ratio, Platelet/Lymphocyte Ratio, and Thrombocytosis in the Preoperative Investigation of Ovarian Masses.
    Yoshida A; Sarian LO; Marangoni M; Firmano IC; Derchain SF
    Rev Bras Ginecol Obstet; 2020 Jul; 42(7):397-403. PubMed ID: 32559800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk - Combined Results from Two Screening Trials.
    Skates SJ; Greene MH; Buys SS; Mai PL; Brown P; Piedmonte M; Rodriguez G; Schorge JO; Sherman M; Daly MB; Rutherford T; Brewster WR; O'Malley DM; Partridge E; Boggess J; Drescher CW; Isaacs C; Berchuck A; Domchek S; Davidson SA; Edwards R; Elg SA; Wakeley K; Phillips KA; Armstrong D; Horowitz I; Fabian CJ; Walker J; Sluss PM; Welch W; Minasian L; Horick NK; Kasten CH; Nayfield S; Alberts D; Finkelstein DM; Lu KH
    Clin Cancer Res; 2017 Jul; 23(14):3628-3637. PubMed ID: 28143870
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical Value of Serum HE4, CA125, CA72-4, and ROMA Index for Diagnosis of Ovarian Cancer and Prediction of Postoperative Recurrence.
    Wang Q; Wu Y; Zhang H; Yang K; Tong Y; Chen L; Zhou Q; Guan S
    Clin Lab; 2019 Apr; 65(4):. PubMed ID: 30969083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment.
    Cho H; Hur HW; Kim SW; Kim SH; Kim JH; Kim YT; Lee K
    Cancer Immunol Immunother; 2009 Jan; 58(1):15-23. PubMed ID: 18414853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The utility of tumor markers and neutrophil lymphocyte ratio in patients with an intraoperative diagnosis of mucinous borderline ovarian tumor.
    Seckin KD; Karslı MF; Yucel B; Bestel M; Yıldırım D; Canaz E; Akbayır O
    Eur J Obstet Gynecol Reprod Biol; 2016 Jan; 196():60-3. PubMed ID: 26683535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proofs for implementation of higher HE4 and ROMA index cut-off values in ovarian cancer preoperative stratification.
    Špacir Prskalo Z; Bulić P; Langer S; Gaće M; Puljiz M; Danolić D; Alvir I; Mamić I; Šušnjar L; Mayer L
    J Obstet Gynaecol; 2019 Feb; 39(2):195-201. PubMed ID: 30207507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of clinical utility between neutrophil count and neutrophil-lymphocyte ratio in patients with ovarian cancer: a single institutional experience and a literature review.
    Komura N; Mabuchi S; Yokoi E; Kozasa K; Kuroda H; Sasano T; Matsumoto Y; Kimura T
    Int J Clin Oncol; 2018 Feb; 23(1):104-113. PubMed ID: 28951992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining a symptom index, CA125 and HE4 (triple screen) to detect ovarian cancer in women with a pelvic mass.
    Goff BA; Agnew K; Neradilek MB; Gray HJ; Liao JB; Urban RR
    Gynecol Oncol; 2017 Nov; 147(2):291-295. PubMed ID: 28860006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simple laboratory score improves the preoperative diagnosis of adnexal mass.
    Watrowski R; Zeillinger R
    Tumour Biol; 2016 Apr; 37(4):4343-9. PubMed ID: 26499778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HE4, CA125 and risk of ovarian malignancy algorithm (ROMA) as diagnostic tools for ovarian cancer in patients with a pelvic mass: An Italian multicenter study.
    Romagnolo C; Leon AE; Fabricio ASC; Taborelli M; Polesel J; Del Pup L; Steffan A; Cervo S; Ravaggi A; Zanotti L; Bandiera E; Odicino FE; Scattolo N; Squarcina E; Papadakis C; Maggino T; Gion M
    Gynecol Oncol; 2016 May; 141(2):303-311. PubMed ID: 26801941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An association of iNKT+/CD3+/CD161+ lymphocytes in ovarian cancer tissue with CA125 serum concentration.
    Winkler I; Woś J; Bojarska-Junak A; Semczuk A; Rechberger T; Baranowski W; Markut-Miotła E; Tabarkiewicz J; Wolińska E; Skrzypczak M
    Immunobiology; 2020 Nov; 225(6):152010. PubMed ID: 33130518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Use of Platelet/Lymphocyte Ratio and Cancer Antigen 125 Combined with Magnetic Resonance Diffusion-Weighted Imaging in Diagnosis of Recurrent Ovarian Cancer and Neuropathic Pain.
    Wang N; Li C; Yang Y; Guan Y; Wang F; Wang Y; Zhao W
    World Neurosurg; 2021 May; 149():502-510. PubMed ID: 33326856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are predictive of chemotherapeutic response and prognosis in epithelial ovarian cancer patients treated with platinum-based chemotherapy.
    Miao Y; Yan Q; Li S; Li B; Feng Y
    Cancer Biomark; 2016 Jun; 17(1):33-40. PubMed ID: 27314290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.